Malenfant Gavin T. 4
4 · ProMIS Neurosciences Inc. · Filed Oct 30, 2023
Insider Transaction Report
Form 4
Malenfant Gavin T.
Chief Operating Officer
Transactions
- Award
Option (right to buy)
2023-10-26+12,500→ 12,500 totalExercise: $1.87Exp: 2033-10-26→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months.